美國Diatherix  www.diatherix.com
該公司提供一系列有關(guān)院內(nèi)感染快速檢測的服務(wù)
成立于2008年的Diatherix公司是全球首家在“分子鑒別診斷”領(lǐng)域持有CLIA執(zhí)照的參比實(shí)驗(yàn)室.2006年秋，韓健在美國集資創(chuàng)辦的公司Genaco被世界上最大的分子診斷公司QIAGEN以4000萬美金收購后，即加入哈森成為研究員。Diatherix公司的實(shí)驗(yàn)室主任。
eurofins收購Diatherix

DIATHERIX Laboratories is an emerging leader in infectious disease diagnostics and drug resistance detection services. Using a multiplexing platform, DIATHERIX Laboratories has developed a series of molecular differential diagnostic services that enable unprecedented speed and accuracy for health care providers in the identification of disease-producing pathogens, leading to appropriate treatment for patients. DIATHERIX Laboratories is a CLIA certified laboratory that is also involved with clinical trials for future products and pharmaceutical development.